예측 기간
시장 규모(기준 연도)
시장 규모(예측 연도)
연평균 성장률>북미 생물정보학 시장, 유형별(지식 관리 도구, 생물정보학 소프트웨어 및 서비스), 부문별(의료 생명공학, 학계, 동물 생명공학, 농업 생명공학, 환경 생명공학, 법의학 생명공학 및 기타), 응용 분야별(유전체학 및 약물 개발, 단백체학, 진화 연구, 농업 연구, 수의학, 대사 체학 , 전사체학 및 기타), 구매 모드(단체 구매 및 개별 구매), 방법별(유전체학 및 단백체학), 최종 사용자(연구 및 학술 기관, 임상 연구 기관, 생명공학 및 제약 회사, 연구소, 병원 및 기타) - 산업 동향 및 2029년까지의 예측.
북미 생물정보학 시장 분석 및 통찰력
생물정보학 시장 성장을 주도하는 요인은 염기당 유전자 시퀀싱 비용 감소, 생물정보학에 대한 수요 증가, 주요 시장 참여자가 제공하는 광범위한 제품 포트폴리오, 개인화된 의료에서 생물정보학 사용, 생물정보학에 대한 공공-민간 부문 자금 지원 증가입니다. 그러나 시장 성장을 억제할 것으로 예상되는 요인은 계측 비용 상승, 임상 생물정보학 분석의 어려움, 생물정보학의 사이버 보안입니다.
반면, 시장 참여자의 전략적 이니셔티브, 제품 개발, 생물정보학 기술의 발전 및 의료비 지출 증가는 생물정보학 시장 성장의 기회로 작용할 수 있습니다. 그러나 숙련된 전문성의 필요성, 임상 실험실에서 생물정보학 기술을 구현하는 데 따른 과제 및 규제 승인은 생물정보학 시장에 과제를 안겨줄 수 있습니다. 전 세계 생물정보학 시장과 관련된 최근의 발전이 있습니다.
약물 개발 및 설계에서 생물정보학을 사용하는 데 대한 수요가 증가함에 따라 북미 시장 성장이 촉진될 것으로 예상됩니다. Data Bridge Market Research는 북미 생물정보학 시장이 2022년에서 2029년까지의 예측 기간 동안 21.8%의 CAGR로 성장할 것으로 분석합니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2022년부터 2029년까지 |
|
기준 연도 |
2021 |
|
역사적 연도 |
2020 (2019-2014까지 사용자 정의 가능) |
|
양적 단위 |
수익은 백만 달러, 가격은 미화로 표시됨 |
|
다루는 세그먼트 |
유형별(지식 관리 도구, 생물정보학 소프트웨어 및 서비스), 부문별(의료 생명공학, 학계, 동물 생명공학, 농업 생명공학, 환경 생명공학, 법의학 생명공학 및 기타), 응용 분야별(유전체학 및 약물 개발, 프로테오믹스, 진화 연구, 농업 연구, 수의학, 대사체학, 전사체학 및 기타), 구매 방식(단체 구매 및 개별 구매), 방법별(유전체학 및 프로테오믹스) 최종 사용자(연구 및 학술 기관, 임상 연구 기관, 바이오텍 및 제약 회사, 연구 실험실, 병원 및 기타) |
|
적용 국가 |
미국, 캐나다, 멕시코 |
|
Market Players Covered |
Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Water Corporation, Partek Incorporated, DNASTAR, Dassault Systèmes, Bayer AG, DNANEXUS, INC., PerkinElmer Inc., Seven Bridges Genomics, Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam, GenoFAB, Inc. Among others |
Market Definition
Bioinformatics combines computer programming, big data, and Molecular Biology, which enables scientists to understand and identify patterns in biological data. It is particularly useful in studying genomes and DNA sequencing, as it allows scientists to organize large amounts of data.
From genetics to toxicology to mycology and radiobiology, there are scores of branches of Biology to specialize in. And out of the many, Bioinformatics is one of the intriguing fields which enables you to identify, evaluate, store, and retrieve biological information. Being an interdisciplinary field of study, it incorporates various applications of Computer Science, Statistics, and Biology to develop software applications for understanding biological data like DNA sequencing, protein analysis, evolutionary genetics, etc.
In the coming future, important decisions related to bioinformatics on drug discovery will be made by individuals who not only understand the biology but can also use the bioinformatics tools and the knowledge they release to develop hypotheses and identify quality targets
North America Bioinformatics Market Dynamics
Drivers
- Decrease in The Cost of Genetic Sequencing Per Base
Oral health is one of the most important aspects of maintaining the health of gums, teeth and the oral-facial system, which allows for speaking, chewing and smiling. According to World Health Organization's report on March 25th, 2020, around 2.3 billion people worldwide are suffering from caries of a permanent tooth, among which around 530 million children suffer from caries of the primary tooth. In North America, periodontal disease has a high prevalence among all age groups. Thereby due to rising periodontal dental disorders, the availability and usage of intraoral scanners are anticipated to boost the market's growth.
- Growing Need for Bioinformatics
As genomics-focused pharmacology continues to play a greater role in the treatment of various chronic diseases, especially cancer, next-generation sequencing (NGS) is evolving as a powerful tool for providing a deeper and more precise insight into the molecular underpinnings of individual tumors and specific receptors. Informatics is essential in biological research involving biologists who learn programming, computer programmers, mathematicians, or database managers who learn the foundations of biology.
Opportunities
- Product Development in Recent Years
The growth curve for bioinformatics market clinical applications is following an upward trend as established applications are gaining momentum and new ones are finding a foothold. Product development in the past years has helped the market size to grow. This also shows the support of the regulatory agency for allowing these products in the market.
For instance-
- In June 2021, Agilent Technologies, Inc. released a new exome design called Sure Select Human All Exon V8 that offers specific content and current coverage of protein-coding areas from Refuses, CCDS and GENCODE. Additionally, it includes exons that are challenging to capture and the TERT promoter, which are neglected by competing exomes
The product development in recent years has shown the potential of these technologies and the companies working in this market are trying to get the more advanced product in the market, which is expected to create a lucrative opportunity for market growth in the forecast period.
- Strategic Initiatives by Market Players
The demand for bioinformatics is increasing in the market owing to the increased levels of research and development along with the growth of the bioinformatics services market aided by the desire for innovative medications. Thus, the top market players have implemented a new strategy by developing new products and collaborating with other market players to improve business operations and profitability.
For instance-
- In January 2020, Charles River underwent a strategic alliance with FiOS Genomics to acquire knowledge in bioinformatics, statistics and biology to help with the collection and analysis of high-dimensional, multi-variant datasets related to drug development, such as microarrays, next-generation sequencing (NGS), proteomics, metabolomics and epigenetics, as well as the related meta-data
These strategic initiatives by the market players, including acquisition, conferences and focused segment product launches, are helping them grow and improve the company's product portfolio, ultimately leading to more revenue generation. Hence, these strategic initiatives by the market players may be expected to as an opportunity that is expected to drive market growth.
Restraints/Challenges
- Difficulty in Clinical Bioinformatics Analysis
The largely untapped potential of big data analytics is a feed buzz that has been exacerbated by the production of many next-generation data sets that seek to answer long-standing questions about the biology of human diseases. Although these approaches are likely to be a powerful means of unveiling new biological insights, several significant challenges currently hinder efforts to harness the power of big data. Typical challenges include the effective assessment of analytical software tools, the speeding up of the overall process using hybrid parallel computing (HPC) parallelization and acceleration technology, the advancement of automation strategies, data storage alternatives, and, finally, the development of new methods for the full utilization of results across multiple experimental conditions.
- Challenges to Implementing Bioinformatics Technology in The Clinical Labs
Bioinformatics technologies can perform massively complicated biological data analysis. This capacity simultaneously facilitates the computational tools for the organization and analysis of biological data, which helps improve diagnostic screening. The application of these powerful technologies in a clinical laboratory poses a challenge because of the data's scope, quantity and medico-technical consequences.
Various challenges of implementing next-generation sequencing in the clinical laboratory are as follows-
- One of the first areas where problems can creep in is often the most overlooked: "sample quality". Although platforms are often tested and compared using highly curated samples (such as the reference material from the Genome in a Bottle Consortium), real-world samples often present much more of a challenge and hence act as a challenge for the rise in demand
- High turn-around time is also a major challenge for the instruments working in this market
COVID-19 Impact on the North America Bioinformatics Market
During the pandemic, the North Bioinformatics sector is one that focuses on using a combination of biology and information technology. At the heart of the industry is biological data, which is analyzed and transformed using IT techniques. Bioinformatics has always had huge potential in providing essential support to many areas of scientific research. The tools that Bioinformatics can provide allow scientists to get to grips with larger data sets and to mine and analyze them to discover crucial information that could lead to key discoveries. Genetics and genomes have been the primary focus of Bioinformatics in recent years, including comparative genomics, DNA microarrays, and functional genomics.
Recent Developments
- 2022년 3월, Thermo Fisher Scientific Inc는 임상 실험실에서 사용할 수 있는 CE-IVD 마크가 있는 차세대 시퀀싱(NGS) 기기를 출시했습니다. CE-IVD 마크가 있는 차세대 시퀀싱 기기는 단일 기기에서 진단 테스트와 임상 연구를 수행하는 데 사용됩니다. 이 기기를 출시하면서 제품군에 새로운 제품이 추가되었고 NGS 기기가 유통되어 제품 수익이 증가할 것으로 예상됩니다.
북미 생물정보학 시장 범위
북미 생물정보학 시장은 유형, 부문, 응용 프로그램, 구매 모드, 유전체학, 최종 사용자라는 6개 세그먼트를 기준으로 세분화됩니다. 이러한 세그먼트 간의 성장은 산업의 빈약한 성장 세그먼트를 분석하고 사용자에게 핵심 시장 응용 프로그램을 식별하기 위한 전략적 결정을 내리는 데 도움이 되는 귀중한 시장 개요와 시장 통찰력을 제공하는 데 도움이 됩니다.
유형
- 지식 관리 도구
- 생물정보학 소프트웨어
- 서비스
북미 생물정보학 시장은 유형을 기준으로 지식 관리 도구, 생물정보학 소프트웨어, 서비스로 구분됩니다.
부문
- 의료 생명공학
- 학업
- 동물 생명공학
- 농업생명공학
- 환경생물공학
- 법의학 생명공학
- 기타
북미 생물정보학 시장은 분야별로 의료 생명공학, 학술 생명공학, 동물 생명공학, 농업 생명공학, 환경 생명공학, 법의학 생명공학 등으로 구분됩니다.
애플리케이션
- 유전체학 및 약물 개발
- 프로테오믹스
- 진화 연구
- 농업 연구
- 수의학
- 대사체학
- 전사체학
- 기타
북미 생물정보학 시장은 응용 분야별로 유전체학 및 약물 개발, 단백체학, 진화 연구, 농업 연구, 수의학, 대사 체학, 전사체학 등으로 구분됩니다.
구매 모드
- 단체구매
- 개별 구매
구매 방식을 기준으로 북미 생물정보학 시장은 단체 구매와 개별 구매로 구분됩니다.
방법
- 유전체학
- 프로테오믹스
방법을 기준으로 북미 생물정보학 시장은 유전체학 및 단백체학으로 구분됩니다.
최종 사용자
- 연구 및 학술 기관
- 임상 연구 기관
- 바이오텍 및 제약 회사
- 연구실
- 병원
- 기타
최종 사용자를 기준으로 북미 생물정보학 시장은 연구 및 학술 기관, 임상 연구 기관, 생명공학 및 제약 회사, 연구 실험실, 병원 등으로 구분됩니다.
파이프라인 분석
북미 생물정보학 시장 지역 분석/통찰력
북미 생물정보학 시장을 분석하고, 위에 참조된 대로 지역, 유형, 부문, 응용 분야, 구매 모드, 유전체학 및 최종 사용자별로 시장 규모에 대한 통찰력과 추세를 제공합니다.
북미 생물정보학 시장 보고서에서 다루는 국가는 미국, 캐나다, 뉴멕시코입니다. 미국은 치주 질환 발병률 증가, 의료 관광 증가, 생물정보학 기술 혁신 성장, 연구 개발 활동 증가로 인해 시장을 지배할 것으로 예상됩니다.
보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변경 사항을 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 질병 역학 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 브랜드의 존재 및 가용성과 지역 및 국내 브랜드의 대규모 또는 희소한 경쟁으로 인해 직면한 과제가 판매 채널에 미치는 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 북미 생물정보학 시장 점유율 분석
북미 생물정보학 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 북미 지역, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우위가 있습니다. 위에 제공된 데이터 포인트는 북미 생물정보학 시장과 관련된 회사의 초점에만 관련이 있습니다.
북미 생물정보학 시장의 주요 기업으로는 Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Water Corporation, Partek Incorporated, DNASTAR, Dassault Systèmes, Bayer AG, DNANEXUS, INC., PerkinElmer Inc., Seven Bridges Genomics, Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam, GenoFAB, Inc. 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA BIOINFORMATICS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 TYPE SEGMENT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 THE CATEGORY VS TIME GRID
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
5 REGULATIONS OF THE NORTH AMERICA BIOINFORMATICS MARKET
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 DECREASE IN THE COST OF GENETIC SEQUENCING PER BASE
6.1.2 GROWING NEED FOR BIOINFORMATICS
6.1.3 WIDE PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYERS
6.1.4 USE OF BIOINFORMATICS IN PERSONALIZED MEDICINE
6.1.5 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS
6.2 RESTRAINTS
6.2.1 HIGH COST OF INSTRUMENTATION
6.2.2 DIFFICULTY IN CLINICAL BIOINFORMATICS ANALYSIS
6.2.3 CYBER SECURITY CONCERNS IN BIOINFORMATICS
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER
6.3.2 PRODUCT DEVELOPMENT IN RECENT YEARS
6.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY
6.4 CHALLENGES
6.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM BIOINFORMATICS TECHNOLOGY
6.4.2 CHALLENGES TO IMPLEMENTING BIOINFORMATICS TECHNOLOGY IN THE CLINICAL LABS
7 NORTH AMERICA BIOINFORMATICS MARKET, BY TYPE
7.1 OVERVIEW
7.2 SERVICES
7.2.1 DIAGNOSTICS CONSULTATION
7.2.2 DATA ANALYSIS
7.2.2.1 STRUCTURAL
7.2.2.2 FUNCTIONAL
7.3 BIOINFORMATICS SOFTWARE
7.3.1 INFORMATICS INFRASTRUCTURE AND PIPELINE SETUP
7.3.2 SAMPLE AND EXPERIMENT MANAGEMENT
7.3.3 SEQUENCING DATA ANALYSIS
7.3.3.1 SEQUENCE ANALYSIS PLATFORM
7.3.3.2 SEQUENCE ALIGNMENT PLATFORM
7.3.3.3 SEQUENCE MANIPULATION PLATFORM
7.3.3.4 STRUCTURAL ANALYSIS PLATFORM
7.3.3.5 OTHERS
7.3.4 BIOLOGICAL DATA INTERPRETATION
7.3.5 SPECIALIZED BIOINFORMATICS APPLICATIONS
7.3.5.1 SINGLE CELL GENE EXPRESSION
7.3.5.2 GENE EXPRESSION
7.3.5.3 VARIANT DETECTION
7.3.5.4 CNV ANALYSIS
7.3.5.5 METAGENOMICS
7.3.5.6 METHYLATION
7.3.5.7 CHIP-SEQ
7.3.5.8 NON-CODING RNA EXPRESSION
7.3.5.9 OTHERS
7.3.6 OTHERS
7.4 KNOWLEDGE MANAGEMENT TOOLS
7.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS
7.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS
8 NORTH AMERICA BIOINFORMATICS MARKET, BY SECTOR
8.1 OVERVIEW
8.2 MEDICAL BIOTECHNOLOGY
8.3 ACADEMICS
8.4 ANIMAL BIOTECHNOLOGY
8.5 AGRICULTURAL BIOTECHNOLOGY
8.6 ENVIRONMENTAL BIOTECHNOLOGY
8.7 FORENSIC BIOTECHNOLOGY
8.8 OTHERS
9 NORTH AMERICA BIOINFORMATICS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 GENOMICS & DRUG DEVELOPMENT
9.2.1 SERVICES
9.2.2 SEQUENCING PLATFORMS
9.2.3 KNOWLEDGE MANAGEMENT TOOLS
9.2.4 GENOMICS & DRUG DEVELOPMENT BY TYPE
9.2.4.1 PREVENTIVE MEDICINE
9.2.4.2 MOLECULAR MEDICINE
9.2.4.3 PERSONALIZED MEDICINE
9.2.4.4 CHEMOINFORMATICS AND DRUG DESIGN
9.2.4.5 ANTIBIOTIC RESISTANCE
9.3 PROTEOMICS
9.3.1 SERVICES
9.3.2 SERVICES SEQUENCING PLATFORMS
9.3.3 KNOWLEDGE MANAGEMENT TOOLS
9.4 AGRICULTURAL STUDIES
9.4.1 SERVICES
9.4.2 SERVICES SEQUENCING PLATFORMS
9.4.3 KNOWLEDGE MANAGEMENT TOOLS
9.5 TRANSCRIPTOMICS
9.5.1 SERVICES
9.5.2 SERVICES SEQUENCING PLATFORMS
9.5.3 KNOWLEDGE MANAGEMENT TOOLS
9.6 METABOLOMICS
9.6.1 SERVICES
9.6.2 SERVICES SEQUENCING PLATFORMS
9.6.3 KNOWLEDGE MANAGEMENT TOOLS
9.7 EVOLUTIONARY STUDIES
9.7.1 SERVICES
9.7.2 SERVICES SEQUENCING PLATFORMS
9.7.3 KNOWLEDGE MANAGEMENT TOOLS
9.8 VETERINARY SCIENCE
9.8.1 SERVICES
9.8.2 SERVICES SEQUENCING PLATFORMS
9.8.3 KNOWLEDGE MANAGEMENT TOOLS
9.9 OTHERS
9.9.1 SERVICES
9.9.2 SERVICES SEQUENCING PLATFORMS
9.9.3 KNOWLEDGE MANAGEMENT TOOLS
10 NORTH AMERICA BIOINFORMATICS MARKET, BY PURCHASE MODE
10.1 OVERVIEW
10.2 GROUP PURCHASE
10.3 INDIVIDUAL PURCHASE
11 NORTH AMERICA BIOINFORMATICS MARKET, BY METHOD
11.1 OVERVIEW
11.2 GENOMICS
11.2.1 DNA
11.2.2 RNA
11.3 PROTEOMICS
12 NORTH AMERICA BIOINFORMATICS MARKET, BY END USER
12.1 OVERVIEW
12.2 RESEARCH AND ACADEMIC INSTITUTES
12.3 CLINICAL RESEARCH ORGANIZATION
12.4 BIOTECH AND PHARMACEUTICAL COMPANIES
12.5 RESEARCH LABORATORIES
12.6 HOSPITALS
12.7 OTHERS
13 NORTH AMERICA BIOINFORMATICS MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA BIOINFORMATICS MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 BAYER AG
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 THERMO FISHER SCIENTIFIC INC
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 EUROFINS SCIENTIFIC
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 DASSAULT SYSTÈMES
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 AGILENT TECHNOLOGIES, INC
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 ASTRIDBIO TECHNOLOGIES INC.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 BGI (A SUBSIDIARY OF BGI GROUP)
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 BIOBAM
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 DNANEXUS INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 DNASTAR
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 GENOFAB, INC
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 ILLUMINA, INC
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENTS
16.13 PARTEK INCORPORATED
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENTS
16.14 PERKINELMER INC.
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENTS
16.15 QIAGEN
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 QUEST DIAGNOSTICS INCORPORATED (2021)
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 SEVEN BRIDGES GENOMICS
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 SOPHIA GENETICS
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENTS
16.19 STRAND LIFE SCIENCES
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 WATERS CORPORATION
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
표 목록
TABLE 1 BIOINFORMATICSCOST PER SAMPLE
TABLE 2 NORTH AMERICA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 3 NORTH AMERICA SERVICES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 NORTH AMERICA SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 NORTH AMERICA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 10 NORTH AMERICA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 NORTH AMERICA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 12 NORTH AMERICA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 13 NORTH AMERICA MEDICAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 NORTH AMERICA ACADEMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 NORTH AMERICA ANIMAL TECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 NORTH AMERICA ENVIRONMENTAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 NORTH AMERICA FORENSIC BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 NORTH AMERICA OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 NORTH AMERICA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 21 NORTH AMERICA GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 NORTH AMERICA GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 23 NORTH AMERICA GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 24 NORTH AMERICA PROTEOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 26 NORTH AMERICA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 NORTH AMERICA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA METABOLOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 NORTH AMERICA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 34 NORTH AMERICA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 NORTH AMERICA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 36 NORTH AMERICA OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 NORTH AMERICA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 38 NORTH AMERICA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 39 NORTH AMERICA GROUP PURCHASE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 40 NORTH AMERICA INDIVIDUAL PURCHASE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 NORTH AMERICA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 42 NORTH AMERICA GENOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 43 NORTH AMERICA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 44 NORTH AMERICA PROTEOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 45 NORTH AMERICA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 46 NORTH AMERICA RESEARCH AND ACADEMIC INSTITUTES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 47 NORTH AMERICA CLINICAL RESEARCH ORGANIZATION IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 48 NORTH AMERICA BIOTECH AND PHARMACEUTICAL COMPANIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 49 NORTH AMERICA RESEARCH LABORATORIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 50 NORTH AMERICA HOSPITALS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 NORTH AMERICA OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 52 NORTH AMERICA BIOINFORMATICS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 53 NORTH AMERICA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 54 NORTH AMERICA SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 55 NORTH AMERICA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 56 NORTH AMERICA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 57 NORTH AMERICA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 58 NORTH AMERICA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 59 NORTH AMERICA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 60 NORTH AMERICA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 61 NORTH AMERICA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 62 NORTH AMERICA GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 63 NORTH AMERICA GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 64 NORTH AMERICA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 65 NORTH AMERICA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 66 NORTH AMERICA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 67 NORTH AMERICA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 68 NORTH AMERICA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 69 NORTH AMERICA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 70 NORTH AMERICA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 71 NORTH AMERICA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 72 NORTH AMERICA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 73 NORTH AMERICA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 74 NORTH AMERICA. BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 75 U.S. BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 76 U.S. SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 77 U.S. DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 78 U.S. BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 79 U.S. SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 80 U.S. SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 81 U.S. KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 82 U.S. BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 83 U.S. BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 84 U.S. GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 85 U.S. GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 86 U.S. PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 87 U.S. AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 88 U.S. TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 89 U.S. METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 90 U.S. EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 91 U.S. VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 92 U.S. OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 93 U.S. BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 94 U.S. BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 95 U.S GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 96 U.S. BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 97 CANADA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 98 CANADA SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 99 CANADA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 100 CANADA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 101 CANADA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 102 CANADA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 103 CANADA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 104 CANADA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 105 CANADA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 106 CANADA GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 107 CANADA GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 108 CANADA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 109 CANADA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 110 CANADA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 111 CANADA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 112 CANADA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 113 CANADA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 114 CANADA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 115 CANADA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 116 CANADA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 117 CANADA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 118 CANADA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 119 MEXICO BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 120 MEXICO SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 121 MEXICO DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 122 MEXICO BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 123 MEXICO SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 124 MEXICO SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 125 MEXICO KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 126 MEXICO BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 127 MEXICO BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 128 MEXICO GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 129 MEXICO GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 130 MEXICO PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 131 MEXICO AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 132 MEXICO TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 133 MEXICO METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 134 MEXICO EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 135 MEXICO VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 136 MEXICO OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 137 MEXICO BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 138 MEXICO BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 139 MEXICO GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 140 MEXICO BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
그림 목록
FIGURE 1 NORTH AMERICA BIOINFORMATICS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA BIOINFORMATICS MARKET: GEOGRAPHIC SCOPE
FIGURE 3 NORTH AMERICA BIOINFORMATICS MARKET: DATA TRIANGULATION
FIGURE 4 NORTH AMERICA BIOINFORMATICS MARKET: SNAPSHOT
FIGURE 5 NORTH AMERICA BIOINFORMATICS MARKET: BOTTOM-UP APPROACH
FIGURE 6 NORTH AMERICA BIOINFORMATICS MARKET: TOP-DOWN APPROACH
FIGURE 7 NORTH AMERICA BIOINFORMATICS MARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 NORTH AMERICA BIOINFORMATICS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA BIOINFORMATICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA BIOINFORMATICS MARKET: APPLICATION COVERAGE GRID
FIGURE 11 NORTH AMERICA BIOINFORMATICS MARKET: THE CATEGORY VS TIME GRID
FIGURE 12 NORTH AMERICA BIOINFORMATICS MARKET SEGMENTATION
FIGURE 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE NORTH AMERICA DENTAL LABMARKET AND IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 14 GROWING APPLICATIONS OF BIOINFORMATICS AND LOW COST OF BIOINFORMATICS SEQUENCING ARE EXPECTED TO DRIVE THE MARKET FOR NORTH AMERICA BIOINFORMATICS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 15 SERVICES SEGMENT ARE EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA BIOINFORMATICS MARKET IN 2019 & 2026
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA BIOINFORMATICS MARKET
FIGURE 17 DECREASE IN COST OF PER BASE SEQUENCING
FIGURE 18 GROWING NEED FOR BIOINFORMATICS IN VITAL APPLICATIONS
FIGURE 19 NORTH AMERICA BIOINFORMATICS MARKET: BY TYPE, 2021
FIGURE 20 NORTH AMERICA BIOINFORMATICS MARKET: BY TYPE, 2022-2029 (USD MILLION)
FIGURE 21 NORTH AMERICA BIOINFORMATICS MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 22 NORTH AMERICA BIOINFORMATICS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 23 NORTH AMERICA BIOINFORMATICS MARKET: BY SECTOR, 2021
FIGURE 24 NORTH AMERICA BIOINFORMATICS MARKET: BY SECTOR, 2022-2029 (USD MILLION)
FIGURE 25 NORTH AMERICA BIOINFORMATICS MARKET: BY SECTOR, CAGR (2022-2029)
FIGURE 26 NORTH AMERICA BIOINFORMATICS MARKET: BY SECTOR, LIFELINE CURVE
FIGURE 27 NORTH AMERICA BIOINFORMATICS MARKET: BY APPLICATION, 2021
FIGURE 28 NORTH AMERICA BIOINFORMATICS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 29 NORTH AMERICA BIOINFORMATICS MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 30 NORTH AMERICA BIOINFORMATICS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 31 NORTH AMERICA BIOINFORMATICS MARKET: BY PURCHASE MODE, 2021
FIGURE 32 NORTH AMERICA BIOINFORMATICS MARKET: BY PURCHASE MODE, 2022-2029 (USD MILLION)
FIGURE 33 NORTH AMERICA BIOINFORMATICS MARKET: BY PURCHASE MODE, CAGR (2022-2029)
FIGURE 34 NORTH AMERICA BIOINFORMATICS MARKET: BY PURCHASE MODE, LIFELINE CURVE
FIGURE 35 NORTH AMERICA BIOINFORMATICS MARKET: BY METHOD, 2021
FIGURE 36 NORTH AMERICA BIOINFORMATICS MARKET: BY METHOD, 2022-2029 (USD MILLION)
FIGURE 37 NORTH AMERICA BIOINFORMATICS MARKET: BY METHOD, CAGR (2022-2029)
FIGURE 38 NORTH AMERICA BIOINFORMATICS MARKET: BY METHOD, LIFELINE CURVE
FIGURE 39 NORTH AMERICA BIOINFORMATICS MARKET: BY END USER, 2021
FIGURE 40 NORTH AMERICA BIOINFORMATICS MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 41 NORTH AMERICA BIOINFORMATICS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 42 NORTH AMERICA BIOINFORMATICS MARKET: BY END USER, LIFELINE CURVE
FIGURE 43 NORTH AMERICA BIOINFORMATICS MARKET: SNAPSHOT (2021)
FIGURE 44 NORTH AMERICA BIOINFORMATICS MARKET: BY COUNTRY (2021)
FIGURE 45 NORTH AMERICA BIOINFORMATICS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 46 NORTH AMERICA BIOINFORMATICS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 47 NORTH AMERICA BIOINFORMATICS MARKET: BY TYPE (2022-2029)
FIGURE 48 NORTH AMERICA BIOINFORMATICS MARKET: COMPANY SHARE 2021 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
